Psoriasis and comorbid diseases: epidemiology
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …
Psoriasis: comorbidities
F Yamazaki - The Journal of dermatology, 2021 - Wiley Online Library
Psoriasis has long been known as a disease with many complications, but was attributed to
diet and obesity. However, in recent years, psoriasis itself has been recognized as a series …
diet and obesity. However, in recent years, psoriasis itself has been recognized as a series …
Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week
Psoriasis is a chronic inflammatory skin disease that affects 2% to 3% of the US population.
The immune response in psoriasis includes enhanced activation of T cells and myeloid …
The immune response in psoriasis includes enhanced activation of T cells and myeloid …
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
JJ Wu, A Kavanaugh, MG Lebwohl… - Journal of the …, 2022 - Wiley Online Library
Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …
[HTML][HTML] Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks
E von Stebut, K Reich, D Thaçi, W Koenig… - Journal of Investigative …, 2019 - Elsevier
Psoriasis increases the risk of cardiovascular (CV) disease. Secukinumab, a fully human
monoclonal antibody against IL-17A, shows significant efficacy in psoriasis, but effects on …
monoclonal antibody against IL-17A, shows significant efficacy in psoriasis, but effects on …
Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment
SCS Hu, CCE Lan - International journal of molecular sciences, 2017 - mdpi.com
Psoriasis is a common and chronic inflammatory disease of the skin. It may impair the
physical and psychosocial function of patients and lead to decreased quality of life …
physical and psychosocial function of patients and lead to decreased quality of life …
Psoriasis and comorbid diseases: Implications for management
As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …
Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities
Psoriasis is a chronic, systemic immune-mediated disease characterized by development of
erythematous, indurated, scaly, pruritic plaques on the skin. Psoriasis is frequently …
erythematous, indurated, scaly, pruritic plaques on the skin. Psoriasis is frequently …
Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index
Importance Psoriasis is a chronic inflammatory skin disease associated with increased
coronary plaque burden and cardiovascular events. Biologic therapy for psoriasis has been …
coronary plaque burden and cardiovascular events. Biologic therapy for psoriasis has been …
PET/MR imaging of inflammation in atherosclerosis
Myocardial infarction, stroke, mental disorders, neurodegenerative processes, autoimmune
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …